The Hyaluronic Acid recommendation was downgraded one level due to a lack of generalized results.
Twenty-eight studies (17 high-strength (Chevalier 2010, Petterson 2018, Maheu 2019, Neustadt 2005, Baltzer 2009, Lundsgaard 2008, Altman 2004, Huang 2011, van der Weergen 2015, Altman 2009, Day 2004, Jorgensen 2010, Henrotin 2017, Henderson 1994, Hangody 2018, Saccomanno 2016, Altman 1998) and 11 moderate-strength (Jubb 2003, Navarro-Sarabia 2011, Farr 2019, Kahan 2003, Kahan 2003, Karlsson 2002, Hermans 2019, Huskisson 1999, Heybeli 2008, Petrella 2006, Takamura 2018, Wobig 1998)) assessed intraarticular hyaluronic acid (HA) injections when compared to controls. A comparison of patients from these studies and from studies validating the MCIDs were used to judge clinical significance. Results revealed that patients were demographically comparable for WOMAC and VAS pain as well as WOMAC function based on age, baseline pain scores, BMI, weight, and gender. Meta-analysis in meaningfully important difference (MID) units showed that the effect was less than 0.5 MID units, indicating a low likelihood that an appreciable number of patients achieved clinically important benefits after intraarticular HA injection (Guyatt et al.). When we differentiated high- versus low- molecular weight viscosupplementation (three high, two moderate and two low quality studies), our analyses demonstrated no significant differences among different viscosupplementation formulations. Crosslinking features of the viscosupplemtation product was assessed in two high quality studies. In patients with OA, there was no difference between cross-linked and non-cross-linked HA.
Some studies demonstrated a statistical benefit with the use of HA but could not reach the significance for a minimally clinical meaningful difference, leading to the conclusion that viscosupplementation can represent a viable option for some patients that failed other treatments when appropriately indicated. The number needed to treat to see a tangible benefit from HA was 17 patients. Furthermore, this difference was most evident at 6 weeks and 3 months. Most of the studies that exist in the literature evaluate low to moderate arthritic knees (Kellgren Lawrence of I-III) with worse results in patients with severely affected knees (KL IV).
The 2013 edition of this guideline strongly recommended against the use of viscosupplementation. In contrast to this updated version, the 2021 version found that statistically significant improvements were associated with high-molecular cross-linked hyaluronic acid but when compared to mid-range molecular weight, statistical significance was not maintained. This newer analysis did not demonstrate clinically relevant differences when compared to controls. However, as previous research reported benefits in their use, the group felt that a specific subset of patients might benefit from its use.
Benefits/Harms of Implementation
There are no major known or anticipated harms associated with implementing this recommendation.
Cost Effectiveness/Resource Utilization
The cost-effectiveness of different intra-articular therapies is still to be determined, in comparison to other treatment strategies and among different intra-articular alternatives.
Currently intra-articular treatments are commonly utilized approach in treating symptomatic knee osteoarthritis, hence there should be no issues implementing this recommendation as it does not influence a major change in clinical practice, and it provides further evidence to support and guide these practices.
These recommendations do not interfere with other interventions or clinical practice therefore it is deemed very feasible in patients with symptomatic knee osteoarthritis.
Future research in this area should embrace detailed osteoarthritis characterization including sub-group analyses and osteoarthrosis severity stratification. Furthermore, using clinically relevant outcomes and controls for bias are warranted along with cost-effectiveness analysis.
- Baltzer AW,Moser C,Jansen SA,Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage 2009;17(2):152-160.
- Altman, R. D., Akermark, C., Beaulieu, A. D., Schnitzer, T. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis and Cartilage 2004; 8: 642-649
- Altman, R. D., Moskowitz, R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. Journal of Rheumatology 1998; 11: 2203-2212
- Altman, R. D., Rosen, J. E., Bloch, D. A., Hatoum, H. T., Korner, P. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Seminars in Arthritis and Rheumatism 2009; 1: 1â?9
- Chevalier, X., Jerosch, J., Goupille, P., van Dijk, N., Luyten, F. P., Scott, D. L., Bailleul, F., Pavelka, K. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Annals of the Rheumatic Diseases 2010; 1: 113â?119
- Day, R., Brooks, P., Conaghan, P. G., Petersen, M. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. Journal of Rheumatology 2004; 4: 775â?782
- Farr, J., Gomoll, A. H., Yanke, A. B., Strauss, E. J., Mowry, K. C., A. S. A. Study Group A Randomized Controlled Single-Blind Study Demonstrating Superiority of Amniotic Suspension Allograft Injection Over Hyaluronic Acid and Saline Control for Modification of Knee Osteoarthritis Symptoms. The Journal of Knee Surgery; 11: 1143-1154
- Guyatt GH, Thorlund K, Oxman AD, et al. Grade Guidelines 13. Preparing Summary of Findings Tables and Evidence Profiles—Continuous Outcomes. Journal of Clinical Epidemiology 2013; 66(2): 173-183.
- Hangody, L., Szody, R., Lukasik, P., Zgadzaj, W., Lenart, E., Dokoupilova, E., Bichovsk, D., Berta, A., Vasarhelyi, G., Ficzere, A., Hangody, G., Stevens, G., Szendroi, M. Intraarticular Injection of a Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Trial. Cartilage 2018; 3: 276-283
- Henderson, E. B., Smith, E. C., Pegley, F., Blake, D. R. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Annals of the Rheumatic Diseases 1994; 8: 529-534
- Henrotin, Y., Berenbaum, F., Chevalier, X., Marty, M., Richette, P., Rannou, F. Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial. BMC Musculoskeletal Disorders 2017; 1: 222
- Hermans, J., Bierma-Zeinstra, S. M. A., Bos, P. K., Niesten, D. D., Verhaar, J. A. N., Reijman, M. The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: A randomised controlled trial. BMC Musculoskeletal Disorders 2019; 1:
- Heybeli, N., Doral, M. N., Atay, O. A., Leblebicioglu, G., Uzumcugil, A. [Intra-articular sodium hyaluronate injections after arthroscopic debridement for osteoarthritis of the knee: a prospective, randomized, controlled study]. Acta Orthopaedica et Traumatologica Turcica 2008; 4: 221-7
- Huang, T. L., Chang, C. C., Lee, C. H., Chen, S. C., Lai, C. H., Tsai, C. L. Intra-articular injections of sodium hyaluronate (Hyalgan) in osteoarthritis of the knee. a randomized, controlled, double-blind, multicenter trial in the Asian population. BMC Musculoskeletal Disorders 2011; 0: 221
- Huskisson EC,Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford) 1999;38(7):602-607.
- Jorgensen, A., Stengaard-Pedersen, K., Simonsen, O., Pfeiffer-Jensen, M., Eriksen, C., Bliddal, H., Pedersen, N. W., Bodtker, S., Horslev-Petersen, K., Snerum, L. O., Egund, N., Frimer-Larsen, H. Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double- blind study of 337 patients followed for 1 year. Annals of the Rheumatic Diseases 2010; 6: 1097-102
- Jubb, R. W., Piva, S., Beinat, L., Dacre, J., Gishen, P. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. International Journal of Clinical Practice 2003; 6: 467â?474
- Kahan, A., Lleu, P. L., Salin, L. Prospective randomized study comparing the medicoeconomic benefits of Hylan GF-20 vs. conventional treatment in knee osteoarthritis. Joint, bone, spine 2003; 4: 276â?281
- Kahan, A., Uebelhart, D., De Vathaire, F., Delmas, P. D., Reginster, J. Y. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis and Rheumatism 2009; 2: 524-533
- Karlsson, J., Sjagren, L. S., Lohmander, L. S. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford, England) 2002; 11: 1240-1248
- Lundsgaard, C., Dufour, N., Fallentin, E., Winkel, P., Gluud, C. Intra-articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial. Scandinavian Journal of Rheumatology 2008; 2: 142-150
- Maheu, E., Avouac, B., Dreiser, R. L., Bardin, T. A single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate vs 0.8% hylan G-F 20 in the treatment of symptomatic knee osteoarthritis: A 6-month, multicenter, randomized, controlled non-inferiority trial. PLoS ONE [Electronic Resource] ; 12: e0226007
- Navarro SF,Coronel P,Collantes E,Navarro FJ,de la Serna AR,Naranjo A,Gimeno M,Herrero BG,-AMELIA-study-group. A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Annals of the Rheumatic Diseases 2011;70:1957-1962.
- Neustadt, D., Caldwell, J., Bell, M., Wade, J., Gimbel, J. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. Journal of Rheumatology 2005; 10: 1928- 1936
- Petrella, R. J., Petrella, M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. Journal of Rheumatology 2006; 5: 951- 956
- Petterson, S. C., Plancher, K. D. Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial. Knee Surgery, Sports Traumatology, Arthroscopy 2018; 0: 29
- Saccomanno, M. F., Donati, F., Careri, S., Bartoli, M., Severini, G., Milano, G. Efficacy of intra-articular hyaluronic acid injections and exercise-based rehabilitation programme, administered as isolated or integrated therapeutic regimens for the treatment of knee osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy 2016; 5: 1686-94
- Takamura, J., Seo, T., Strand, V. A Single Intra-Articular Injection of Gel-200 for Treatment of Symptomatic Osteoarthritis of the Knee Is More Effective than Phosphate Buffered Saline at 6 Months: A Subgroup Analysis of a Multicenter, Randomized Controlled Trial. Cartilage 2018; 0: 1947603518768015
- van der Weegen, W., Wullems, J. A., Bos, E., Noten, H., van Drumpt, R. A. No difference between intra-articular injection of hyaluronic acid and placebo for mild to moderate knee osteoarthritis: a randomized, controlled, double-blind trial. Journal of Arthroplasty 2015; 5: 754-7
- Wobig, M., Dickhut, A., Maier, R., Vetter, G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clinical Therapeutics 1998; 3: 410-423